{"id":"https://openalex.org/W2591554907","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","title":"Emerging concepts in combination chemotherapy for metastatic pancreatic cancer: A systematic review of randomized controlled trials.","display_name":"Emerging concepts in combination chemotherapy for metastatic pancreatic cancer: A systematic review of randomized controlled trials.","publication_year":2013,"publication_date":"2013-02-01","ids":{"openalex":"https://openalex.org/W2591554907","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","mag":"2591554907"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.4_suppl.228","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032269053","display_name":"Basile M. Njei","orcid":"https://orcid.org/0000-0003-0714-4368","observed_orcids":["https://orcid.org/0000-0003-0714-4368"]},"institutions":[{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Basile M. Njei","raw_affiliation_strings":["University of Connecticut School of Medicine, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut School of Medicine, Farmington, CT","institution_ids":["https://openalex.org/I75929689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037950578","display_name":"Ivo Che Ditah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivo C. Ditah","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048464614","display_name":"Alexei Shimanovsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexei Shimanovsky","raw_affiliation_strings":["University of Connecticut, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut, Farmington, CT","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024672023","display_name":"Priscilla Owusu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priscilla Owusu","raw_affiliation_strings":["University of Connecticut, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut, Farmington, CT","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106235397","display_name":"John W. Birk","orcid":"https://orcid.org/0000-0003-2717-0723","observed_orcids":["https://orcid.org/0000-0003-2717-0723"]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]},{"id":"https://openalex.org/I75929689","display_name":"UConn Health","ror":"https://ror.org/02kzs4y22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I75929689"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John W Birk","raw_affiliation_strings":["University of Connecticut, Farmington, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut, Farmington, CT","institution_ids":["https://openalex.org/I140172145","https://openalex.org/I75929689"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"4_suppl","first_page":"228","last_page":"228"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9350000023841858},{"id":"https://openalex.org/keywords/folfirinox","display_name":"FOLFIRINOX","score":0.996999979019165},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.7979999780654907},{"id":"https://openalex.org/keywords/platinum-agents","display_name":"platinum agents","score":0.6610000133514404},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7919999957084656},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8659999966621399},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8629999756813049},{"id":"https://openalex.org/keywords/hedgehog-pathway-inhibitors","display_name":"Hedgehog pathway inhibitors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9359629154205322},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8833904266357422},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.7716330289840698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.752489447593689},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7430146932601929},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6724967956542969},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6269649863243103},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.5915506482124329},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5749281048774719},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.48230576515197754},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4315280318260193},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4262031316757202},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4188508093357086},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3976549208164215},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.16089320182800293}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.4_suppl.228","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.4_suppl.228","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410815619","https://openalex.org/W2151253787","https://openalex.org/W2418647446","https://openalex.org/W4283170015","https://openalex.org/W2903623792","https://openalex.org/W2256750991","https://openalex.org/W2113566724","https://openalex.org/W1941634770","https://openalex.org/W2782140564","https://openalex.org/W1974922522"],"abstract_inverted_index":{"228":[0],"Background:":[1],"Even":[2,251],"though":[3],"gemcitabine":[4,180,228,249],"monotherapy":[5,181],"is":[6,46,255,285],"commonly":[7],"used":[8],"as":[9,294],"first-line":[10],"treatment":[11,18,76],"for":[12,119,172],"metastatic":[13,80,244],"pancreatic":[14,81,245],"cancer,":[15],"many":[16],"novel":[17,290],"approaches":[19],"have":[20],"focused":[21],"on":[22],"combination":[23,27,175,230,291],"chemotherapy.":[24],"FOLFIRINOX,":[25],"a":[26,54,88,277],"of":[28,57,66,77,91,221,270,273,280],"5-fluorouracil,":[29],"leucovorin,":[30],"irinotecan,":[31],"and":[32,96,102,132,165,191,203,298],"oxaliplatin,":[33],"has":[34],"recently":[35],"been":[36],"shown":[37],"to":[38,42,60,70,109,248,276],"improve":[39,238],"survival":[40,49,127,130,240,259,265],"compared":[41,247],"gemcitabine.":[43],"However,":[44],"it":[45],"unclear":[47],"whether":[48],"benefits":[50],"are":[51],"counterbalanced":[52],"by":[53],"poor":[55],"quality":[56,272],"life":[58,274],"due":[59,275],"the":[61,92,149,173,179,263,268],"adverse":[62,134,214,281],"effects.":[63],"The":[64,210],"aim":[65],"this":[67],"study":[68],"was":[69,152,217],"review":[71],"emerging":[72],"strategies":[73],"that":[74,186],"enhance":[75],"patients":[78,145,188,222,242],"with":[79,189,224,231,243,257],"cancer.":[82],"Methods:":[83],"Two":[84],"authors":[85],"independently":[86],"conducted":[87],"comprehensive":[89],"search":[90],"Cochrane":[93],"library":[94],"PUBMED,":[95],"published":[97,113],"proceedings":[98],"from":[99,106,287],"major":[100],"oncologic":[101],"gastrointestinal":[103],"cancer":[104,246],"meetings":[105],"January":[107],"1980":[108],"July":[110],"2012.":[111],"Only":[112],"randomized":[114],"controlled":[115],"trials":[116],"were":[117,146],"eligible":[118],"inclusion.":[120],"Our":[121],"primary":[122],"outcome":[123],"measures":[124],"were:":[125],"progression-free":[126],"(PFS),":[128],"overall":[129,154,239],"(OS)":[131],"serious":[133],"events":[135],"(grade":[136],"3":[137],"or":[138,233],"4).":[139],"Results:":[140],"Thirty-one":[141],"studies":[142,288],"involving":[143,289],"7,957":[144],"included":[147],"in":[148,158,219,229,241],"analysis.":[150],"There":[151],"an":[153],"statistically":[155],"significant":[156],"increase":[157],"OS":[159],"(RR":[160,167],"1.10,":[161],"95%":[162,169,200,206],"CI":[163,170,201,207],"1.03-1.30)":[164],"PFS":[166],"1.27,":[168],"1.14-1.46)":[171],"gemcitabine-based":[174],"therapy":[176,254,292],"group":[177],"versus":[178],"group.":[182],"Subgroup":[183],"analysis":[184],"showed":[185,195],"only":[187],"fluoropyrimidine":[190,232],"platinum":[192,234],"containing":[193,235],"regimens":[194,236],"prolonged":[196,264],"survival:":[197],"RR":[198,204],"1.33,":[199],"1.04-1.76":[202],"1.38,":[205],"1.08-1.76,":[208],"respectively.":[209],"most":[211],"common":[212],"severe":[213],"event":[215],"(neutropenia)":[216],"found":[218],"45%":[220],"treated":[223],"FOLFIRINOX.":[225],"Conclusions:":[226],"Overall,":[227],"can":[237],"alone.":[250],"though,":[252],"FOLFIRINOX":[253],"associated":[256],"better":[258],"outcomes":[260],"than":[261],"gemcitabine,":[262],"comes":[266],"at":[267],"cost":[269],"poorer":[271],"higher":[278],"incidence":[279],"events.":[282],"More":[283],"data":[284],"needed":[286],"such":[293],"hedgehog":[295],"pathway":[296],"inhibitors":[297],"radio-immunotherapy.":[299]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}